ARHGEF3 and hepatocellular carcinoma: Given the observed inhibition of HCV replication by ARHGEF3 following infection of Huh7 human hepatoma cells, we wanted to determine whether the gene was expressed in chronically HCV-infected liver in vivo where it could also contribute to controlling viral replication.